The Effects of Injected Vitamin D on Prognosis of Patients with Urosepsis

Horm Metab Res. 2018 May;50(5):383-388. doi: 10.1055/a-0595-7731. Epub 2018 Apr 5.

Abstract

The aim of this study was to evaluate the effect of prescribing vitamin D on improving the symptoms of patients diagnosed with urosepsis. The participants were randomly divided into two equal groups (each consisting of 50 patients). The patients in the first group received standard treatment with 300 000 units of injected vitamin with a volume of 1 cc. As for the patients in the second group, they received standard treatment along with 1 cc normal saline injected to them as placebo. Vital signs of the patients were checked every 6 h, while their CBC, EXR, CRP, creatinine, urea, and uric acid were checked 0, 24, 48, and 72 h following the interventions. Calcium, phosphorus, and vitamin D levels were measured 72 h following injection of the medicine. A significant difference was observed between the two groups in terms of the number of WBC's in 24th, 48th, and 72nd hours. A similarly significant difference was reported between the case and control group in terms of the average BUN within 24th, 48th, and 72nd hours. The difference observed between the two groups in terms of average Cr within the 0th, 24th, 48th, and 72nd hours and in terms of days of hospitalization was also significant. Considering these results and keeping in mind the fact that no particular side effects were reported as a result of utilizing muscular injections of vitamin D and the easy and cheap use of this medicine, it can be used in auxiliary treatment of patients with urosepsis.

Publication types

  • Randomized Controlled Trial

MeSH terms

  • Aged
  • Female
  • Humans
  • Male
  • Middle Aged
  • Sepsis / blood*
  • Sepsis / drug therapy*
  • Urinary Tract Infections / blood*
  • Urinary Tract Infections / drug therapy*
  • Vitamin D / administration & dosage*

Substances

  • Vitamin D